Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV.
Frontiers in immunology（2023）
摘要
https://beta.clinicaltrials.gov/study/NCT05075070, identifier NCT05075070.
更多查看译文
关键词
dosing interval,inactivated COVID-19 vaccination,neutralizing antibody,people living with HIV,seroconversion
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要